JP2025081549A5 - - Google Patents

Info

Publication number
JP2025081549A5
JP2025081549A5 JP2025025886A JP2025025886A JP2025081549A5 JP 2025081549 A5 JP2025081549 A5 JP 2025081549A5 JP 2025025886 A JP2025025886 A JP 2025025886A JP 2025025886 A JP2025025886 A JP 2025025886A JP 2025081549 A5 JP2025081549 A5 JP 2025081549A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
amino acid
light chain
chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025025886A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025081549A (ja
Filing date
Publication date
Priority claimed from JP2022502245A external-priority patent/JP7695228B2/ja
Application filed filed Critical
Publication of JP2025081549A publication Critical patent/JP2025081549A/ja
Publication of JP2025081549A5 publication Critical patent/JP2025081549A5/ja
Pending legal-status Critical Current

Links

JP2025025886A 2019-07-15 2025-02-20 ヒト及びイヌctla-4に対するイヌ化抗体 Pending JP2025081549A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962874287P 2019-07-15 2019-07-15
US62/874,287 2019-07-15
JP2022502245A JP7695228B2 (ja) 2019-07-15 2020-07-15 ヒト及びイヌctla-4に対するイヌ化抗体
PCT/EP2020/069924 WO2021009188A1 (en) 2019-07-15 2020-07-15 Caninized antibodies to human and canine ctla-4

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022502245A Division JP7695228B2 (ja) 2019-07-15 2020-07-15 ヒト及びイヌctla-4に対するイヌ化抗体

Publications (2)

Publication Number Publication Date
JP2025081549A JP2025081549A (ja) 2025-05-27
JP2025081549A5 true JP2025081549A5 (cg-RX-API-DMAC10.html) 2025-10-10

Family

ID=71620455

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022502245A Active JP7695228B2 (ja) 2019-07-15 2020-07-15 ヒト及びイヌctla-4に対するイヌ化抗体
JP2025025886A Pending JP2025081549A (ja) 2019-07-15 2025-02-20 ヒト及びイヌctla-4に対するイヌ化抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022502245A Active JP7695228B2 (ja) 2019-07-15 2020-07-15 ヒト及びイヌctla-4に対するイヌ化抗体

Country Status (8)

Country Link
US (1) US12552864B2 (cg-RX-API-DMAC10.html)
EP (1) EP3999539A1 (cg-RX-API-DMAC10.html)
JP (2) JP7695228B2 (cg-RX-API-DMAC10.html)
CN (2) CN114174336B (cg-RX-API-DMAC10.html)
AU (1) AU2020312687B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022000604A2 (cg-RX-API-DMAC10.html)
CA (1) CA3145347A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021009188A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114174336B (zh) * 2019-07-15 2024-10-11 英特维特国际股份有限公司 针对人和犬ctla-4的犬源化抗体
KR20250137204A (ko) 2022-12-27 2025-09-17 인베티엑스 인코포레이티드 신생아 fc 수용체(fcrn)에 대한 결합이 변경된 폴리펩타이드 및 사용 방법
CN121002059A (zh) 2023-01-20 2025-11-21 因外泰克斯公司 用于伴侣动物的双特异性结合剂
CN117343185B (zh) * 2023-12-06 2024-03-01 北京伟杰信生物科技有限公司 一种抗犬pd-1抗体及其用途

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
GB2183662B (en) 1985-04-01 1989-01-25 Celltech Ltd Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6096002A (en) 1998-11-18 2000-08-01 Bioject, Inc. NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
US6682736B1 (en) * 1998-12-23 2004-01-27 Abgenix, Inc. Human monoclonal antibodies to CTLA-4
ES2706547T3 (es) 1998-12-23 2019-03-29 Pfizer Anticuerpos monoclonales humanos para CTLA-4
EP2275540B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
US7605238B2 (en) 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
NZ517202A (en) * 1999-08-24 2004-05-28 Medarex Inc Human CTLA-4 antibodies and their uses
US6703360B2 (en) * 2000-04-07 2004-03-09 Heska Corporation Compositions and methods related to canine IgG and canine IL-13 receptors
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
CA2469833C (en) * 2001-12-21 2008-05-20 Idexx Laboratories, Inc. Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
KR100845354B1 (ko) 2004-03-26 2008-07-09 화이자 프로덕츠 인코포레이티드 항-ctla-4 항체의 용도
CN101688925B (zh) * 2007-01-15 2012-12-26 拉皮斯坎系统股份有限公司 检测器系统
GB0903325D0 (en) 2009-02-26 2009-04-08 Univ Aberdeen Antibody molecules
CA2754408A1 (en) * 2009-03-30 2010-10-14 Boehringer Ingelheim International Gmbh Fusion proteins comprising canine fc portions
BR112012022338A2 (pt) * 2010-03-04 2017-02-14 Vet Therapeutics Inc anticorpos monoclonais direcionados a cd20
GB201103955D0 (en) * 2011-03-09 2011-04-20 Antitope Ltd Antibodies
US8790651B2 (en) * 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
HK1201281A1 (en) * 2011-10-13 2015-08-28 Nexvet Australia Pty Ltd Canine/feline cd20 binding epitope and compositions for binding thereto
US9617334B2 (en) 2012-06-06 2017-04-11 Zoetis Services Llc Caninized anti-NGF antibodies and methods thereof
AU2014368453B2 (en) 2013-12-20 2020-04-16 Intervet International B.V. Caninized murine anti-canine PD-1 antibodies
ES2853823T3 (es) 2014-09-30 2021-09-17 Intervet Int Bv Anticuerpos de PD-L1 que se unen a PD-L1 canino
EP3954710A3 (en) * 2015-04-02 2022-07-20 Intervet International B.V. Antibodies to canine interleukin-4 receptor alpha
WO2017062615A2 (en) 2015-10-08 2017-04-13 Macrogenics, Inc. Combination therapy for the treatment of cancer
CN108367069B (zh) * 2015-12-14 2022-08-23 宏观基因有限公司 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法
ES3014160T3 (en) 2015-12-18 2025-04-21 Intervet Int Bv Caninized human antibodies to human and canine il-4r alpha
NL2017270B1 (en) 2016-08-02 2018-02-09 Aduro Biotech Holdings Europe B V New anti-hCTLA-4 antibodies
HUE065861T2 (hu) * 2016-08-26 2024-06-28 Sanofi Sa Szelektív könnyûlánc-párosítást elõsegítõ multispecifikus antitestek
JP2022500037A (ja) * 2018-09-14 2022-01-04 キンドレッド バイオサイエンシズ インコーポレイテッド 獣医学的使用のための抗il4受容体抗体
CN114174336B (zh) * 2019-07-15 2024-10-11 英特维特国际股份有限公司 针对人和犬ctla-4的犬源化抗体

Similar Documents

Publication Publication Date Title
AU2018203170B2 (en) Multimeric Fusion Protein Vaccine And Immunotherapeutic
JP2021524270A5 (cg-RX-API-DMAC10.html)
US7786269B2 (en) Antibody to latent membrane proteins and uses thereof
JP2025109759A5 (cg-RX-API-DMAC10.html)
JP2638652B2 (ja) カケクチンと反応するモノクロナール抗体
JP2021524275A5 (cg-RX-API-DMAC10.html)
EP3572125A2 (en) Monoclonal antibodies for ebola and marburg viruses
JP2022505445A5 (cg-RX-API-DMAC10.html)
WO2017198212A1 (zh) 针对ctla4的单域抗体及其衍生蛋白
JP2026510999A (ja) Cd19/cd38多重特異性抗体
CN115461078A (zh) 通过与改变的Fc片段形成融合蛋白增强蛋白/肽抗原免疫原性的方法
CN102690789B (zh) 分泌破伤风外毒素单克隆抗体的杂交瘤细胞株及由其制备的单克隆抗体、Fab抗体与应用
EP4628095A1 (en) Fusion protein and granulated antigen comprising same
CN117903301A (zh) 特异性结合轮状病毒的抗体或其抗原结合片段
WO2014043215A1 (en) Bi-specifc diabodies for masking and targeting vaccines
CN113549147B (zh) 抗柯萨奇a6型病毒的单克隆抗体及其应用
CA2539172C (fr) Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine
CN102558306B (zh) 旋毛虫副肌球蛋白b细胞抗原表位、其组合物及用途
JPWO2020071554A5 (cg-RX-API-DMAC10.html)
CN118085082A (zh) 抗猫TNF-α单克隆抗体及其应用
WO2008107641A1 (en) Liposome preparation
CN120904320B (zh) 一种牙鲆弹状病毒重组单链可变区抗体及其应用
JP5435539B2 (ja) 抗体産生細胞の活性化ペプチド
Coelho Isolation of human recombinant antibodies anti-SARS-CoV-2 by synthetic methods
KR102180731B1 (ko) 탄저독소 중화 항체 및 이를 포함하는 약제학적 조성물